PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 259 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240 | -59.9% | 7,749 | -48.2% | 0.05% | -58.2% |
| Q2 2023 | $598 | -65.0% | 14,953 | -64.1% | 0.11% | -67.6% |
| Q1 2023 | $1,709 | +4.5% | 41,688 | -0.5% | 0.34% | -4.2% |
| Q4 2022 | $1,635 | -99.9% | 41,918 | -3.4% | 0.35% | -33.6% |
| Q3 2022 | $2,299,000 | +24.5% | 43,378 | +36.2% | 0.53% | +28.1% |
| Q2 2022 | $1,847,000 | +689.3% | 31,844 | +932.2% | 0.42% | +845.5% |
| Q1 2022 | $234,000 | – | 3,085 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |